Anthony El-Khoueiry, MD

Articles by Anthony El-Khoueiry, MD

Selection and Use of Systemic Therapy in Intermediate Stage HCC

ByTanios Bekaii-Saab, MD,Anthony El-Khoueiry, MD,Pierre Gholam, MD,Arndt Vogel, MD,Mark Yarchoan, MD

July 13th 2022

Panelists consider the role of systemic therapy in patients with intermediate-stage HCC who are ineligible for locoregional therapy.

Dr. El-Khoueiry Discusses Recent Combination Data in HCC

ByAnthony El-Khoueiry, MD

October 17th 2018

Anthony El-Khoueiry, MD, associate professor of clinical medicine, Keck School of Medicine, USC Norris Comprehensive Cancer Center, discusses recent combination data in hepatocellular carcinoma.

Anthony El-Khoueiry, MD

Articles by Anthony El-Khoueiry, MD

Selection and Use of Systemic Therapy in Intermediate Stage HCC

Dr. El-Khoueiry Discusses Recent Combination Data in HCC

Trending on OncLive

Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma

PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer

FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma

Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies